THERAPEUTIKA
European patent · EP2144905 · Deleted
Register entry
- Publication number
- EP2144905
- Application number
- EP08742520
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 3, 2008
- Published
- Jan 20, 2010
- Granted
- Nov 28, 2012
- Deleted
- Apr 30, 2018
- Reason
- Annual fee unpaid
- IPC classes
- C07D 417/12 (2006.01)A61K 31/428 (2006.01)A61P 25/18 (2006.01)A61P 25/22 (2006.01)A61P 25/28 (2006.01)
- Priority
- US 921759 P 04.04.2007
- PCT application
- PCT/US2008/004336 03.04.2008
- PCT publication
- WO2008/124030 16.10.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 21, 2018
Deleted, fee unpaid
Published in Swissreg on 21.11.2018
- Jun 8, 2017
Transferred
- Owner
- Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA → Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan
Published in Swissreg on 08.06.2017
- Jan 22, 2013
Agent entered
- Representative
- Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich
Published in Swissreg on 22.01.2013
- Nov 28, 2012
Granted
Published in Swissreg on 28.11.2012
Parties
Holder
Inventor
BILODEAU, Mark, T.
Rahway, New Jersey 07065-0907, US
NANDA, Kausik, K.
Rahway, New Jersey 07065-0907, US
TROTTER, B. Wesley
Rahway, New Jersey 07065-0907, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.